FDA approves Actavis’ generic Suboxone ANDA to treat opioid dependence

NewsGuard 100/100 Score
Feb 26 2013

Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg, the generic equivalent to Reckitt Benckiser Healthcare's Suboxone®.  

Actavis intends to begin shipping the product immediately.  Suboxone® is indicated for maintenance treatment of opioid dependence. 

For the 12 months ending December 31, 2012, Suboxone® tablets had total U.S. sales of approximately $625 million, according to IMS Health data.

Source:

Actavis, Inc.

Posted in: Medical Condition News | Pharmaceutical News

Tags: , , , , , , , ,

Comments (3)

Suggested Reading

Maternal influences on food allergy prevention: A closer look at diet and environment
Food allergies' broad impact on quality of life demands greater awareness
Renaissance of "food as medicine" in modern clinical trials
Korean fermented food Doenjang shows promise in alleviating menopausal symptoms
How can food influence the severity of menopausal hot flashes?
Study links ultra-processed food consumption with higher cardiovascular risk
Ultra-processed foods raise chronic kidney disease risk, study shows
Can you spot the difference? Study explores the appeal of AI-generated vs. real food images

Comments

  1. It's about time!!
    Jeff Tuttle Jeff Tuttle United States says:
    February 28, 2013 at 9:15 AM

    What took so long?? This should have been out years ago!! Suboxone went from $5.00 per pill when it first 4 years it came out to $10.00 today!! DOUBLE the price!!! Now Reckitt Benckiser wants some government protection on the Suboxone "Strip" claiming it is safer?
    There should have be SEVERAL generic versions of this drug by now!!!

    Reply
  2. What took so long?
    Jeff Tuttle Jeff Tuttle United States says:
    February 28, 2013 at 9:19 AM

    What took so long??
    This generic should have been out years ago!!
    Suboxone went from $5.00 per pill retail the first 4 years it came out to $10.00 today!! DOUBLE the price!!! Now Reckitt Benckiser wants some government protection on the Suboxone "Strip" claiming it is safer? BS!!
    There should have be SEVERAL generic versions of this drug by now!!! Someone needs to find out why this generic is just now becoming available!!
    The rise in price (double) is what caused this drug to become a "popular street drug" because of the PRICE!!

    Reply
    • What caused this to just now become available as a generic?
      steven scott steven scott United States says:
      March 14, 2013 at 9:28 PM

      What caused this to just now become available as a generic? I would imagine it is because Reckitt Benckiser's patent on the drug ran out December 31, 2012, allowing other companies to manufacture the drug. I have been taking this for 7 years or so, and it has helped me. but as you said in the years the price has doubled and for the last 2 years the doctors have been hardcore pushing the original companies newish strips or film whatever.

      Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Feeling lonely? It may affect how your brain reacts to food, new research suggests